---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-063699"
form_type: "8-K"
ticker: "CGEM"
cik: "0001789972"
company_name: "Cullinan Therapeutics, Inc."
filed_at: "2022-03-03T23:59:59+00:00"
generated_at: "2026-06-27T02:05:18.392623+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cullinan Oncology hires Jeffrey Jones as CMO and appoints Anne-Marie Martin to board

## Summary
- Jeffrey Jones, M.D., MPH, MBA, appointed CMO effective Feb 28, 2022; previously VP at Bristol Myers Squibb.
- Annual base salary $460,000; sign-on bonus $100,000; option for 215,000 shares at $14.34.
- Dr. Jones' option vests 25% on first anniversary, remainder monthly over three years.
- Anne-Marie Martin, Ph.D., appointed Class I director effective Mar 1, 2022; SVP at GlaxoSmithKline.
- Dr. Martin received option grant with grant-date fair value $350,000 vesting over three years.

## SEC filing metadata
- accession: 0001193125-22-063699
- form_type: 8-K
- ticker: CGEM
- cik: 0001789972
- company_name: Cullinan Therapeutics, Inc.
- filed_at: 2022-03-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789972/000119312522063699/0001193125-22-063699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789972/000119312522063699/d303753d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-063699
- JSON: https://secwatch.observer/filing/0001193125-22-063699.json
- Plain text: https://secwatch.observer/filing/0001193125-22-063699.txt

## Key facts
- Executive change
  Jeffrey Jones was appointed as Chief Medical Officer at Cullinan Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: On February 28, 2022, Cullinan Oncology, Inc. (the “Company”) announced the hiring and appointment of Jeffrey Jones, M.D., MPH, MBA as the Company’s Chief Medical Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1789972/000119312522063699/0001193125-22-063699-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.